- PZU’s third-quarter net income was 1.22 billion zloty, exceeding estimates of 1.2 billion zloty, though it declined by 18% year-over-year.
- Insurance sales reached 7.54 billion zloty, marking an 8.6% increase compared to the previous year and surpassing the estimated 7.44 billion zloty.
- The company reported an operating profit of 4.06 billion zloty, which is a 3.6% decrease year-over-year but still higher than the forecasted 3.89 billion zloty.
- PZU’s net income for the first nine months of the year totaled 3.66 billion zloty, representing a 12% decline year-over-year.
- Analysts’ recommendations include 7 buys and 5 holds, with no sell recommendations.
A look at Powszechny Zaklad Ubezpieczen Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 5 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Powszechny Zaklad Ubezpieczen SA, a company specializing in property and casualty insurance, is looking at a positive long-term outlook based on Smartkarma’s Smart Scores. Topping the charts with a perfect 5 score for dividends, investors can expect solid returns in the form of payouts. Additionally, with a strong value score of 4, the company is deemed to be undervalued in the market, presenting an opportunity for growth. Although the resilience and momentum scores are moderate at 3, the overall outlook remains promising for Powszechny Zaklad Ubezpieczen.
Offering a wide range of non-life insurance products such as fire and automobile insurance, Powszechny Zaklad Ubezpieczen also delves into life insurance through a dedicated division. With favorable scores in value, dividends, and growth, the company appears well-positioned to navigate the competitive insurance landscape and sustain its appeal to investors in the foreseeable future.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
